Skip to main content

Table 3 List of NCCN-recommended systemic anticancer therapies

From: A retrospective cohort study of treatment patterns among patients with metastatic soft tissue sarcoma in the US

NCCN-recommended systemic cancer therapy
Bevacizumab
Carboplatin
Cyclophosphamide
Dacarbazine
Dactinomycin
Docetaxel
Doxorubicin/pegylated liposomal doxorubicin
Epirubicin
Eribulin
Etoposide
Gemcitabine
Ifosfamide
Irinotecan
Paclitaxel
Pazopanib
Sorafenib
Sunitinib
Temozolomide
Topotecan
Trabectedin
Vincristine
Vinorelbine